SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Nargolwala Vineet A

(Last) (First) (Middle)
529 PLEASANT ST

(Street)
ATTLEBORO MA 02703

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2020
3. Issuer Name and Ticker or Trading Symbol
Sensata Technologies Holding plc [ ST ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Sensing Solutions
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value EUR 0.01 per share 28,519(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock options to Buy (2) 02/19/2023 Ordinary Shares, par value EUR 0.01 per share 12,300(3) $33.54 D
Stock options to Buy (2) 04/01/2024 Ordinary Shares, par value EUR 0.01 per share 18,660(4) $43.16 D
Stock options to Buy (2) 04/01/2025 Ordinary Shares, par value EUR 0.01 per share 7,706(5) $56.94 D
Stock options to Buy (6) 04/01/2026 Ordinary Shares, par value EUR 0.01 per share 14,159(7) $38.96 D
Stock options to Buy (8) 04/01/2027 Ordinary Shares, par value EUR 0.01 per share 12,069(9) $43.67 D
Stock options to Buy (10) 04/01/2028 Ordinary Shares, par value EUR 0.01 per share 9,380(11) $51.83 D
Stock options to Buy (12) 04/01/2029 Ordinary Shares, par value EUR 0.01 per share 11,862(13) $46.93 D
Explanation of Responses:
1. Includes unvested performance-based restricted securities granted to the reporting person on various dates as follows:7,157 granted on April 1, 2017; 5,307 granted on April 1, 2018 and 6,446 granted on April 1, 2019. These restricted securities will vest three years after their respective grant date subject to the issuer's satisfaction of certain performance criteria. Also includes unvested time-based restricted securities granted to the reporting person on various dates as follows: 1,718 granted on April 1, 2017; 1,448 granted on April 1, 2018; 1,758 granted on April 1, 2019 and 4,685 granted on June 1, 2019. These restricted securities will vest three years after their respective grant date.
2. These options are currently exercisable.
3. Consists of options granted to the reporting person on February 19, 2013.
4. Consists of options granted to the reporting person on April 1, 2014.
5. Consists of options granted to the reporting person on April 1, 2015.
6. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 10,619 of these options are exercisable.
7. Consists of options granted to the reporting person on April 1, 2016.
8. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 6,034 of these options are exercisable.
9. Consists of options granted to the reporting person on April 1, 2017.
10. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. Currently, 2,345 of these options are exercisable.
11. Consists of options granted to the reporting person on April 1, 2018.
12. These options are exercisable over four years at 25% per year, beginning on the first anniversary date of the grant. None of these options are exercisable.
13. Consists of options granted to the reporting person on April 1, 2019.
Remarks:
/s/ Michael Richards by power of attorney 03/26/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.